Navigation Links
High development costs hinder entry of cancer super drugs into the market

Cancer patients in the future could benefit from pharmacogenomics or the field of personalized medicine where therapies could be tailored to suit individual patients. Few drugs which target specific protein receptors in cancer are already in the market and the decoding of the human genome// offers great promise to patients, as the therapy could become more specialized. However, all this comes with a heavy cost and cancer research experts warn that such breakthroughs may not lead to new treatment due to the cost.

Pharmaceutical companies face formidable problems in this new treatment approach as it costs about $100 million to develop a cancer drug and only about one in ten make it to the market. The developmental costs of these drugs are so high because they are targeted at specific molecules and this requires sophisticated screening tests.

The pharma companies are already pulling out of oncology drugs since the potential market is too small, as the patients treated with a particular drug are confined to a small genetically defined subgroup, and the sales from this small group would not cover the development costs. Unless scientists are able to show that these drugs work on a specific genetic type instead of on only 2 or 3 per cent of patients, these drugs may not make it to the market.

A cancer research expert, Dr. Keith Snell warned that if development costs are not reduced, the new cancer therapies have very slim chances of reaching the cancer patients. He however suggested that the solution lies in simplifying clinical trials and small biotechnology companies, major drug companies and scientific researchers agreeing to share the risks, thereby making the development process a more economic proposition.


Page: 1

Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Role of zinc in development
3. Particulate matter affects lung development
4. Fossil teeth and human development
5. Fireflies help speed development of new drugs
6. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
7. New fertility drug development techniques by Organon
8. Biosensor chip to help drug development
9. Cells critical for asthma development found
10. ICMR along with other International Research organisation with drug development for Neglected Diseases
11. Epilepsy surgery to help child development
Post Your Comments:

(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... District , the only authorized OSHA Training Institute Education Center headquartered in Northern ... protecting their workers from extreme heat at their worksites. Employers with workers ...
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced today its affiliation with Tennessee Counseling Association. This new relationship ... of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... strategic partnership with Connance, a healthcare industry leader providing predictive analytics to ... technology combine to provide health systems, hospitals and ambulatory surgical centers with ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is ... emergency ambulance transport experience for the millions of people who require these medical ... the taxi industry through the use of technology. Now, SmartEMS has put forth ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: